Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017. (2019)

First Author: Gottlieb SL
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2017.10.084

PubMed Identifier: 29224963

Publication URI: http://europepmc.org/abstract/MED/29224963

Type: Journal Article/Review

Volume: 37

Parent Publication: Vaccine

Issue: 50

ISSN: 0264-410X